Removal of oxytetracycline from water by S-doped MIL-53(Fe): Synergistic effect of surface adsorption and persulfate activation.

In this study, a novel catalyst based on MIL-53(Fe) was synthesized and modified through sublimed sulfur (S-MIL-53(Fe)) to induce a synergistic effect of surface adsorption and persulfate activation. The S-doped modification not only increased the surface area but also accelerated the electron transfer process of the iron cycle. The performance of the newly synthesized S-MIL-53(Fe) adsorptive catalyst was evaluated by chemical adsorption and peroxydisulfate (PDS) activated removal of an emerging pollutants, oxytetracycline (OTC). The S-MIL-53(Fe) adsorptive catalyst was able to adsorb 61.7% of OTC after 120 min, and the removal efficiency reached 84.8% within 5 min after PDS dosing. The boosting effect of sulfur on the system was confirmed by characterization analysis and experimental testing. Even after 7 cycles, the removal efficiency of S-MIL-53(Fe) (69.0%) for OTC remained superior to that of pure MIL-53(Fe) (25.1%). Additionally, the adsorption kinetics and adsorption isotherm model of the material were investigated. The possible OTC degrading process was proposed based on radical quenching and electron paramagnetic resonance (EPR). This study provides a feasible way to fabricate an S-doped MIL-53(Fe) adsorptive catalyst for the remediation of antibiotics-containing wastewater.

Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients.

BACKGROUND: Pancreatic cancer (PC) is a malignancy with a poor prognosis and high mortality. Surgical resection is the only "curative" treatment. However, only a minority of patients with PC can obtain surgery. Improving the overall survival (OS) rate of patients with PC is still a major challenge. Molecular biomarkers are a significant approach for diagnostic and predictive use in PCs. Several prediction models have been developed for patients newly diagnosed with PC that is operable or patients with advanced and metastatic PC; however, these models require further validation. Therefore, precise biomarkers are urgently required to increase the efficiency of predicting a disease-free survival (DFS), OS, and sensitivity to immunotherapy in PC patients and to improve the prognosis of PC. METHODS: In the present study, we first evaluated the highly and selectively expressed targets in PC, using the GeoMxTM Digital Spatial Profiler (DSP) and then, we analyzed the roles of these targets in PCs using TCGA database. RESULTS: LAMB3, FN1, KRT17, KRT19, and ANXA1 were defined as the top five upregulated targets in PC compared with paracancer. The TCGA database results confirmed the expression pattern of LAMB3, FN1, KRT17, KRT19, and ANXA1 in PCs. Significantly, LAMB3, FN1, KRT19, and ANXA1 but not KRT17 can be considered as biomarkers for survival analysis, univariate and multivariate Cox proportional hazards model, and risk model analysis. Furthermore, in combination, LAMB3, FN1, KRT19, and ANXA1 predict the DFS and, in combination, LAMB3, KRT19, and ANXA1 predict the OS. Immunotherapy is significant for PCs that are inoperable. The immune checkpoint blockade (ICB) analysis indicated that higher expressions of FN1 or ANXA1 are correlated with lower ICB response. In contrast, there are no significant differences in the ICB response between high and low expression of LAMB3 and KRT19. CONCLUSIONS: In conclusion, LAMB3, FN1, KRT19, and ANXA1 are good predictors of PC prognosis. Furthermore, FN1 and ANXA1 can be predictors of immunotherapy in PCs.

GM-CSF impairs erythropoiesis by disrupting erythroblastic island formation via macrophages.

Anemia is a significant complication of chronic inflammation and may be related to dysregulated activities among erythroblastic island (EBI) macrophages. GM-CSF was reported to be upregulated and attracted as a therapeutic target in many inflammatory diseases. Among EBIs, we found that the GM-CSF receptor is preferentially and highly expressed among EBI macrophages but not among erythroblasts. GM-CSF treatment significantly decreases human EBI formation in vitro by decreasing the adhesion molecule expression of CD163. RNA-sequence analysis suggests that GM-CSF treatment impairs the supporting function of human EBI macrophages during erythropoiesis. GM-CSF treatment also polarizes human EBI macrophages from M2-like type to M1-like type. In addition, GM-CSF decreases mouse bone marrow (BM) erythroblasts as well as EBI macrophages, leading to a reduction in EBI numbers. In defining the molecular mechanism at work, we found that GM-CSF treatment significantly decreases the adhesion molecule expression of CD163 and Vcam1 in vivo. Importantly, GM-CSF treatment also decreases the phagocytosis rate of EBI macrophages in mouse BM as well as decreases the expression of the engulfment-related molecules Mertk, Axl, and Timd4. In addition, GM-CSF treatment polarizes mouse BM EBI macrophages from M2-like type to M1-like type. Thus, we document that GM-CSF impairs EBI formation in mice and humans. Our findings support that targeting GM-CSF or reprogramming EBI macrophages might be a novel strategy to treat anemia resulting from inflammatory diseases.

Evidence of pyroptosis and ferroptosis extensively involved in autoimmune diseases at the single-cell transcriptome level.

BACKGROUND: Approximately 8-9% of the world's population is affected by autoimmune diseases, and yet the mechanism of autoimmunity trigger is largely understudied. Two unique cell death modalities, ferroptosis and pyroptosis, provide a new perspective on the mechanisms leading to autoimmune diseases, and development of new treatment strategies. METHODS: Using scRNA-seq datasets, the aberrant trend of ferroptosis and pyroptosis-related genes were analyzed in several representative autoimmune diseases (psoriasis, atopic dermatitis, vitiligo, multiple sclerosis, systemic sclerosis-associated interstitial lung disease, Crohn's disease, and experimental autoimmune orchitis). Cell line models were also assessed using bulk RNA-seq and qPCR. RESULTS: A substantial difference was observed between normal and autoimmune disease samples involving ferroptosis and pyroptosis. In the present study, ferroptosis and pyroptosis showed an imbalance in different keratinocyte lineages of psoriatic skinin addition to a unique pyroptosis-sensitive keratinocyte subset in atopic dermatitis (AD) skin. The results also revealed that pyroptosis and ferroptosis are involved in epidermal melanocyte destruction in vitiligo. Aberrant ferroptosis has been detected in multiple sclerosis, systemic sclerosis-associated interstitial lung disease, Crohn's disease, and autoimmune orchitis. Cell line models adopted in the study also identified pro-inflammatory factors that can drive changes in ferroptosis and pyroptosis. CONCLUSION: These results provide a unique perspective on the involvement of ferroptosis and pyroptosis in the pathological process of autoimmune diseases at the scRNA-seq level. IFN-γ is a critical inducer of pyroptosis sensitivity, and has been identified in two cell line models.

Influencing factors of treatment and prognosis perceptions among advanced cancer patients: a cross-sectional study.

PURPOSE: The present study aimed to investigate the status and significantly influencing factors of treatment and prognosis perceptions among advanced cancer patients based on patient-reported outcome. METHODS: A cross-sectional study was conducted at two tertiary A general hospitals. From June to September 2019, 300 patients were invited and 292 of them participated in this study. Except for 9 invalid questionnaires, 283 pen-paper questionnaires including sociodemographic and clinical characteristics, Chinese Version of Prognosis and Treatment Perception Questionnaire, Herth Hope Index, and Hospital Anxiety and Depression Scale were well completed. Descriptive analysis, Pearson's correlation test, logistic regression analysis, and multiple linear regression analysis were applied for analysis. RESULTS: One hundred seventy-five (61.8%) advanced cancer patients reported inaccurate treatment perception. Prognosis perception scored 87.9 ± 13.72 indicating a middle level of prognosis perception. Fourteen (4.9%), 138 (48.8%), and 131 (46.3%) patients presented low, middle, and high prognosis perception levels, respectively. In patients, without spouse and religion beliefs, received chemoradiotherapy, diagnosed as cancer equal to or less than 1 year, and higher hope level were inaccurate treatment perception's risk factors. Younger age, longer diagnosis time, higher educational level, less support for medical expenses payment, receiving chemoradiotherapy, and lower hope level but more anxiety and depression symptoms were positive predictors of prognosis perception. CONCLUSIONS: A majority of advanced cancer patients in this study reported inaccurate treatment and middle level of prognosis perception influencing by objective and subjective factors. Clinical interventions could be developed referring these impacting factors originating from patient-reported outcome.

Highly efficient removal of oxytetracycline using activated magnetic MIL-101(Fe)/γ-Fe2O3 heterojunction catalyst.

A novel magnetic nanocomposite MIL-101(Fe)/γ-Fe2O3 was synthesized by hydrothermal method. The physical structure and chemical property of the as-obtained magnetic nanocomposite was characterized. The ability of MIL-101(Fe)/γ-Fe2O3 to promote photo-assisted peroxydisulfate (PDS) activation was investigated by using oxytetracycline (OTC) as the target pollutant. The results showed that the composite with a FeCl3•6H2O: γ-Fe2O3 mass ratio of 10:1 exhibited the highest degradation efficiency (up to 91.2%). Influencing factors such as pH, catalyst dosage, PDS concentration and OTC concentration on the catalytic performance of MIL-101(Fe)/γ-Fe2O3 were also investigated to determine the optimum conditions. More importantly, the MIL-101(Fe)/γ-Fe2O3 can be magnetically recovered and reused for 4 cycles. Based on radical quenching and electron spin resonance (ESR), the possible degradation mechanism of OTC in photo-assisted PDS activation (PPA) system was proposed. This research provided novel insights for the design and preparation of a new type of magnetic Fe-MOFs for environmental remediation.

The characteristics of alkaline phosphatase activity and phoD gene community in heavy-metal contaminated soil remediated by biochar and compost.

This research was carried out to determine the influence of biochar and compost addition on the characteristics of potential alkaline phosphatase (ALP) activity and phoD gene community in heavy metal polluted soils. The ALP activity, the abundance and structure of phoD gene were systematically determined. Results showed that biochar and compost significantly changed soil properties, and promoted the microbial transformation of phosphorus. Compost addition significantly increased the ALP activity. Biochar and compost addition markedly increased the phoD gene abundance. The addition of biochar increased the proportion of Actinobacteria, Euryarchaeota, and Proteobacteria. By contrast, Betaproteobacteria, Deltaproteobacteria, and Gammaproteobacteria were the dominant taxa in soils with compost addition. Electrical conductivity critically controlled the expression of phoD and changed the structure of phoD-coding microbial communities in heavy-metal polluted soils that remediated by biochar and compost.

Glycogen synthase kinase-3ß promotes radiation-induced lung fibrosis by regulating ß-catenin/lin28 signaling network to determine type II alveolar stem cell transdifferentiation state.

The role of type II alveolar epithelial stem cells (AEC II) for alveolar repair in radiation-induced lung fibrosis (RILF) remains largely unknown, mainly because of AEC II phenotype's spontaneous change in vitro. Cell differentiation status is determined by Lin28 and let-7 miRNAs in see-saw-pattern. Lin28, a repressor of let-7 and a stem cell marker, is activated by ß-catenin. The expression of ß-catenin is regulated by GSK-3ß/TGF-ß1 signaling. To understand the true role of AEC II in RILF, we freshly isolated primary AEC II directly from thoracically irradiated lungs. We then explored the expressions of cell phenotype markers and differentiation regulators in these isolated AEC II to analyze the correlation between GSK-3ß/TGF-ß1/ß-catenin signaling pathway, lin28/let-7 balance, and AEC II phenotypes at different injury phases following irradiation. Results showed that isolated single primary cells displayed AEC II ultrastructural features and proSP-C positive. The gene expressions of prosp-c (an AEC II biomarker) and hopx (an AEC I marker) significantly increased in isolated AEC II during injury repair phase (P < .001 and P < .05) but decreased at end-stage of injury, while mesenchymal markers increased in both isolated AEC II and irradiated lungs. mRNA levels of gsk-3ß, tgf-ß1, and ß-catenin increased in all irradiated AEC II, but more pronounced in the second half of injury phase (P < .05-P < .001). Similarly, the expression of lin28 was also significantly elevated in isolated AEC II at the late phase (P < .05-P < .001). Four let-7 miRNAs were significantly upregulated in all irradiated AEC II groups (P < .05-P < .001). The time-dependent and highly consistent uptrends for four lin28/let-7 ratios in sorted AEC II contrasted to downtrends in irradiated lungs. In conclusion, RILF occurred when GSK-3ß/TGF-ß1 signaling increased ß-catenin levels, which led to the augmentation of AEC II population by elevated lin28/let-7 ratio and the transcription of profibrotic cytokines and factors, thereby inducing AEC II to undergo transdifferentiation into mesenchymal cells.

Construction of Z-scheme g-C3N4 / MnO2 /GO ternary photocatalyst with enhanced photodegradation ability of tetracycline hydrochloride under visible light radiation.

A facile wet-chemical method was adopted to synthesize g-C3N4/MnO2/GO heterojunction photocatalyst for visible-light photodegradation of tetracycline hydrochloride (TC). The addition of MnO2 and GO increased the absorption of visible light and the specific surface area of the photocatalyst. The results of photoluminescence, electrochemical impedance spectroscopy, and photocurrent response indicated that CMG-10 had the lowest electron-hole recombination probability, which was beneficial for the photocatalytic reaction. The ternary photocatalyst exhibited enhanced photoelectric performance and superior photocatalytic activity with 91.4% removal of TC (10 mg/L) under a mere 60 min visible light illumination, which showed enhanced photocatalytic degradation when compared with binary (CM, 77.95%; CG, 78.83%) and single (C3N4, 55.5%; MnO2, 36.41%) photocatalysts. A pH of 6 was optimal for the CMG-10 photocatalytic degradation of TC, and the optimal photocatalyst dosage was 0.5 g/L. Common coexisting ions influenced the removal of TC by influencing the production of active species. The catalyst is stable and reusable with only a 10% reduction in removal efficiency after four cycles. According to the active species analysis, the Z-scheme mechanism was a charge transfer behavior in the composite photocatalyst, which could prevent the recombination of photogenerated carriers. This study presents a photocatalytic approach to the effective removal of TC from water bodies, which provides practical implications to advance the use of photocatalytic technology in the restoration of aqueous environmental pollution.

Enhancing autotrophic nitrogen removal with a novel dissolved oxygen-differentiated airlift internal circulation reactor: Long-term operational performance and microbial characteristics.

Autotrophic nitrogen removal (ANR) processes have not been widely applied in wastewater treatment due to their long start-up time and unstable performance. In this study, a novel dissolved oxygen-differentiated airlift internal circulation reactor was developed to enhance ANR from wastewater. During 200 days of continuous operation, the reactor start-up was achieved within 30 days; a high total nitrogen removal efficiency of 80% was achieved and stably maintained under an aeration rate of 0.90 L/min and hydraulic retention time of 6 h. Additionally, the color of sludge went from a light yellow to dark red, and the amount and size of the micro-granules increased obviously. Medium-sized (1.0-2.5 mm) micro-granules accounted for 72.4% on day 190. The specific anammox activity increased from 0.53 to 1.43 g-N/g-VSS/d, while the SNOA decreased from 0.93 to 0.08 g-N/g-VSS/d. Furthermore, the microbial analysis showed that the Nitrosomonas (4.2%) and Candidatus Brocadia (22.6%) were enriched and formed the micro-granules after the reactor's long-term operation. The results indicate that novel configuration realizes the partitioning of dissolved oxygen (DO), optimizes nitritation and anammox reactions, and accelerates biochemical reactions, thereby enhancing ANR performance. This study provides a practical alternative to enhance ANR performance and a scientific basis for the development and application of novel nitrogen removal reactors.

A review on the removal of heavy metals and metalloids by constructed wetlands: bibliometric, removal pathways, and key factors.

Heavy metals and metalloids (HMMs) pose a serious threat to both environmental and human health. The unique characteristics and environmental toxicity of HMMs make their removal from the environment a major challenge. Constructed wetlands (CWs) are increasingly being used as an eco-friendly system for the removal of HMMs from aqueous environments. In this review, bibliometric analysis was performed using the Scopus database using VOSviewer software to assess the developing use of CWs in recent years. Heavy metal and metalloid (HMM) removal pathways were reviewed (such as precipitation, co-precipitation, adsorption and ion exchange, plant action and microbial action) along with the impact of key factors (pH, chemical oxygen demand, dissolved oxygen, HMM concentration, and temperature). This review aimed to establish the connections between published results, to help effectively optimize the use of CWs for the removal of HMMs and identify the most critical factors for their effective removal. Important aspects that require further research include assessing the synergistic toxicity between different pollutants and combining the use of CWs with other technologies to optimize pollutant remediation efficiency.

Exploration of symptom experience in kidney transplant recipients based on symptoms experience model.

PURPOSE: Kidney transplant recipients suffer from a variety of symptoms, and symptom management is crucial in improving their quality of life (QOL). Accordingly, this study aims to identify the symptoms experienced by kidney transplant recipients and examine the relationship amongst antecedents, symptom experience and QOL of recipients in China. METHODS: A total of 300 kidney transplant recipients were investigated in one of the most first-rate hospitals in China by asking them to fill out a self-designed general questionnaire, the Symptom Experience Scale, the Sense of Coherence Scale (Chinese version), the Revised Life Orientation Test (Chinese version) and the 36-item Short Form Health Survey (Chinese version). RESULTS: Kidney transplant recipients experienced multiple symptoms that were frequent, severe and bothersome. The final model showed significant consistency with the data. In the QOL model, post-transplant time, complications, immunosuppressive agents and sense of coherence explained 30.7% of the variance of symptom experience. Moreover, habitual residence, economic burden, post-transplant time, kidney function, optimism and symptom experience accounted for 70.6% of the variance on QOL. CONCLUSIONS: We can explain the relationship between antecedents, symptom experience and QOL amongst Chinese kidney transplant recipients by using Symptoms Experience Model. Clinicians and caregivers can manage the recipient's symptoms during follow-up from psychological, physical and medication management perspectives. Improving sense of coherence, maintaining optimism and managing symptoms are essential for enhancing QOL.

Performance and microbial community variations of a upflow anaerobic sludge blanket (UASB) reactor for treating monosodium glutamate wastewater: Effects of organic loading rate.

To investigate the effect of the organic loading rate (OLR) on anaerobic treatment of monosodium glutamate (MSG) wastewater, a lab-scale up-flow anaerobic blanket (UASB) reactor was continuously operated over a 222-day period. The overall performances of COD removal and methane recovery initially exhibited an increase and subsequently decreased when the OLR was increased from 1 g-COD/L/d to 24 g-COD/L/d. At the optimal OLR of 8 g-COD/L/d, superior performance was obtained with a maximum COD removal efficiency of 97%, a methane production rate of 2.3 L/L/d, and specific methanogenic activity of 86 mg-CH4/g-VSS/d (feeding on glutamate), with superior characteristics of sludge in VSS concentration, average diameter of granules, and settling velocity. According to the results of the specific methanogenic activity, the methanogenic pathway was more inclined to pass through acetate than through hydrogen. Methanosarcina instead of Methanosaeta, with Methanobacterium and greatly increased Firmicutes, dominated in the UASB reactor after long term operation. These results support that the OLR had a substantial effect on both the treatment and energy recovery efficiency of MSG wastewater as well as on microbial community variations in the UASB reactor.

Weakly-coupled 7-core-2-LP-mode transmission using commercial SFP + transceivers enabled by all-fiber spatial multiplexer and demultiplexer.

Spatial division multiplexing transmission over few-mode multicore fiber (FM-MCF) recently attracts great interests by simultaneously exploiting two more dimensions than conventional single mode fibers. In this paper, we propose an all-fiber spatial multiplexer (MUX) by cascading mode-selective fiber couplers (MSCs) with a fiber-bundle-type fan-in device, and spatial demultiplexer (DEMUX) by cascading a fiber-bundle-type fan-out device with degenerate-mode-selective fiber couplers and MSCs. Thanks to the low crosstalk of the FM-MCF, spatial MUX/DEMUX and their coupling, weakly-coupled 7-core-2-LP-mode real-time transmission over 1-km of FM-MCF is successfully demonstrated using 10-Gbps commercial enhanced small form-factor pluggable (SFP + ) transceivers.

Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.

BACKGROUND: The prognosis of patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma is still dismal. There are no standard treatment strategies for these patients. Multidisciplinary team (MDT) approach is a good choice for making a high-quality decision. Generally, MDT will recommend these patients to receive preoperative chemotherapy or preoperative chemoradiation based on all kinds of treatment guidelines. However, the preferred preoperative treatment is still not established. In order to solve this problem, we carry out this randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma. METHODS: Eligible patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma are randomized to receive preoperative chemoradiation or preoperative chemotherapy, followed by surgery and postoperative chemotherapy. In the preoperative chemoradiation arm (Pre-CRT), patients receive two cycles of S-1 and oxaliplatin (SOX), chemoradiation, then followed by surgery and three more cycles of SOX chemotherapy. In the preoperative chemotherapy arm (Pre-CT), patients receive three cycles of SOX, following surgery three more cycles of SOX are given. The primary endpoint of this trial is to verify that preoperative chemoradiation could significantly improve the 3-year disease free survival (DFS) of patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma compared to preoperative chemotherapy. DISCUSSION: The results from this trial will provide important information about whether preoperative chemoradiation could improve survival compared to preoperative chemotherapy among patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03013010. First posted January 6, 2017.

Wet flue gas desulfurization wastewater treatment with reclaimed water treatment plant sludge: a case study.

To upgrade a wet flue gas desulfurization (FGD) wastewater treatment process in a typical thermal power plant (TPP) in Hunan province, China, a new concept for reusing polyaluminum chloride (PAC)-based water treatment plant sludge (WTPS) as a coagulant is proposed. Results show that, for an optimal WTPS dosage of 1,000 mg/L, the corresponding removal capacities for suspended solids (SS) and chemical oxygen demand (COD) from the practical FGD wastewater were 58.3% and 40.3%, respectively. Through an advanced treatment with a dosage of 50 mg/L of PAC, pH of 9, and stirring of 150 r/min for 60 s and 50 r/min for 15 min, the total removal efficiencies of SS, COD, and total cadmium (Cd) from the FGD wastewater were 93.7%, 88.8%, and 84.6%, respectively. Therefore, a new modification process (that involves mixing with WTPS - slag cleaner - neutralization - coagulation - sedimentation) was proposed. The proposed process is economically superior, and the average cost for the FGD wastewater treatment was only 1.08 USD/t. This could provide a cost-effective alternative process for upgrading FGD wastewater treatment facilities of TPPs.

A gold nanoparticle-based colorimetric probe for rapid detection of 1-hydroxypyrene in urine.

Direct and rapid detection of 1-hydroxypyrene (1-OHP) is of great importance owing to its high carcinogenicity, teratogenicity and toxicity. In this study, a simple colorimetric assay for rapid determination of 1-OHP is reported, which is based on non-crosslinking aggregation of gold nanoparticles (Au NPs) induced by 1-OHP in the presence of formic acid (FA). Initially, Au NPs were synthesized with citrate as the capping agent and exhibited red color. Subsequently, the addition of FA did not cause aggregation of Au NPs, but a proton transfer process occurred from FA to carboxylic anions on the surface of Au NPs with a decreased zeta potential. The subsequent addition of 1-OHP resulted in a further decreased zeta potential and an intensely hydrophobic environment, which led to a strong and rapid non-crosslinking aggregation of Au NPs within 5 min with the color changing from red to violet blue. Based on this principle, sensitive and selective detection of 1-OHP was achieved. The detection limit was 3.3 nM. Finally, the colorimetric assay was successfully applied to detect 1-OHP in a urine sample. This strategy provides new insights into developing colorimetric methods for on-site and real-time detection of polycyclic aromatic hydrocarbons.

Prognostic role of microRNA-100 in various carcinomas: evidence from six studies.

Recent studies have shown that microRNAs (miRNA) exhibit altered expression levels in cancers, and they may be considered as valuable prognostic biomarkers for patients with cancers. We performed this meta-analysis to provide a comprehensive evaluation of the role of miRNA-100 expression on the overall survival rate by calculating the pooled hazard ratio (HR) for overall survival (OS), which compared the high and low expression levels of miR-100 in patients of the available studies. Finally, a total of six studies dealing with various carcinomas were involved for this meta-analysis. The results indicated that lower expression of miR-100 in cancerous tissue could significantly predict poorer survival in various carcinomas with the pooled HR of 2.19 (95% CI 1.49-3.24, P = 0.0007). In conclusion, the findings from this present meta-analysis suggest that miR-100 expression is associated with OS in cancer patients and could be a useful clinical prognostic factor for those patients.

Biochar from phytoremediation plant residues: a review of its characteristics and potential applications.

Phytoremediation is a cost-effective and eco-friendly plant-based approach promising technique to repair heavy metal-contaminated soils. However, a significant quantity of plant residues needs to be properly treated and utilized. Pyrolysis is an effective technology for converting residues to biochar, which can solve the problem and avoid secondary contamination. This paper reviews the generation, and physicochemical properties of biochar from phytoremediation residues, and its application in soil improvement, environmental remediation, and carbon sequestration. In spite of this, it is important to be aware of the potential toxicity of heavy metals in biochar and the environmental risks of biochar before applying it to practical applications. Future challenges in the production and application of residue-derived biochar include the rational selection of pyrolysis parameters and proper handling of potentially hazardous components in the biochar.

Identification of potential immune-related mechanisms related to the development of multiple myeloma.

BACKGROUND: Although significant advances have been made in the treatment of multiple myeloma (MM), leading to unprecedented response and survival rates among patients, the majority eventually relapse, and a cure remains elusive. This situation is closely related to an incomplete understanding of the immune microenvironment, especially monocytes/macrophages in patients with treatment-naïve MM. The aim of this study was to provide insight into the immune microenvironment, especially monocytes/macrophages, in patients with treatment-naïve MM. METHODS: This study used the single-cell RNA sequencing (scRNA-seq) data of both patients with MM and heathy donors to identify immune cells, including natural killer (NK) cells, T cells, dendritic cells (DCs), and monocytes/macrophages. Transcriptomic data and flow cytometry analysis of monocytes/macrophages were used to further examine the effect of monocytes/macrophages in treatment-naïve MM patients. RESULTS: A significant difference was observed between the bone marrow (BM) immune cells of the healthy controls and treatment-naïve MM patients through scRNA-seq. It is noteworthy that, through an scRNA-seq data analysis, this study found that interferon (IFN)-induced NK/T cells, terminally differentiated effector memory (TEMRA) cells, T-helper cells characterized by expression of IFN-stimulated genes (ISG + Th cells), IFN-responding exhausted T cells, mannose receptor C-type 1 (MRC1) + DCs, IFN-responding DCs, MHCII + DCs, and immunosuppressive monocytes/macrophages are enriched in patients with treatment-naïve MM. Significantly, transcriptomic data of monocytes/macrophages demonstrated that "don't eat me"-related genes and IFN-induced genes increase in treatment-naïve MM patients. Furthermore, scRNA-seq, transcriptomic data, and flow cytometry also showed an increased proportion of CD16 + monocytes/macrophages and expression level of CD16. Cell-cell communication analysis indicated that monocytes/macrophages, especially the migration inhibitory factor (MIF) and interleukin 16 (IL-16) signaling pathway, are key players in treatment-naïve MM patients. CONCLUSIONS: Our findings provide a comprehensive and in-depth molecular characterization of BM immune cell census in MM patients, especially for monocytes/macrophages. Targeting macrophages may be a novel treatment strategy for patients with MM.